| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.0024 |
0.9 |